DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $498,960 | -6.2% | 2,079 | -1.5% | 0.05% | -13.0% |
| Q1 2023 | $532,056 | +94910.0% | 2,111 | 0.0% | 0.05% | -23.9% |
| Q4 2022 | $560 | -99.9% | 2,111 | 0.0% | 0.07% | -10.1% |
| Q3 2022 | $545,000 | +4.8% | 2,111 | +2.9% | 0.08% | +3.9% |
| Q2 2022 | $520,000 | -13.6% | 2,051 | 0.0% | 0.08% | -8.4% |
| Q1 2022 | $602,000 | -14.9% | 2,051 | -11.6% | 0.08% | -31.4% |
| Q4 2021 | $707,000 | 0.0% | 2,321 | 0.0% | 0.12% | 0.0% |
| Q3 2021 | $707,000 | +8.8% | 2,321 | -4.1% | 0.12% | +65.8% |
| Q2 2021 | $650,000 | -3.3% | 2,421 | -18.9% | 0.07% | -49.7% |
| Q1 2021 | $672,000 | +178.8% | 2,985 | +175.1% | 0.14% | +145.8% |
| Q4 2020 | $241,000 | +3.4% | 1,085 | 0.0% | 0.06% | -10.6% |
| Q3 2020 | $233,000 | +22.0% | 1,085 | 0.0% | 0.07% | +8.2% |
| Q2 2020 | $191,000 | +24.8% | 1,085 | -1.9% | 0.06% | -26.5% |
| Q1 2020 | $153,000 | -7.3% | 1,106 | +2.9% | 0.08% | +6.4% |
| Q4 2019 | $165,000 | +5.8% | 1,075 | 0.0% | 0.08% | -1.3% |
| Q3 2019 | $156,000 | +9.1% | 1,075 | +7.0% | 0.08% | +9.7% |
| Q2 2019 | $143,000 | +22.2% | 1,005 | +14.2% | 0.07% | +24.1% |
| Q1 2019 | $117,000 | +34.5% | 880 | +3.8% | 0.06% | +28.9% |
| Q4 2018 | $87,000 | -5.4% | 848 | 0.0% | 0.04% | +73.1% |
| Q3 2018 | $92,000 | +9.5% | 848 | 0.0% | 0.03% | +4.0% |
| Q2 2018 | $84,000 | -99.9% | 848 | 0.0% | 0.02% | -44.4% |
| Q1 2018 | $83,028,000 | +112100.0% | 848 | +6.0% | 0.04% | +9.8% |
| Q4 2017 | $74,000 | +7.2% | 800 | 0.0% | 0.04% | -4.7% |
| Q3 2017 | $69,000 | +1.5% | 800 | 0.0% | 0.04% | -4.4% |
| Q2 2017 | $68,000 | 0.0% | 800 | 0.0% | 0.04% | -6.2% |
| Q1 2017 | $68,000 | +9.7% | 800 | 0.0% | 0.05% | -4.0% |
| Q4 2016 | $62,000 | – | 800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |